RespireRx Pharmaceuticals Inc (RSPI)

[drfreely]

Still no response from Management from my 11/12/13 query. Jeff Margolis seems to have taken the same approach to investor relations that served the previous management team so well. If there's an effort to commercialize any of the compounds I suppose its best to not get investors hopes up with press releases or communiques. Any increase in share price could prevent whoever's buying from continuing accumulating shares at this price, and might likewise prevent management from weaseling out of debt run up by Varney and friends. These are the only two potentially positive rationalizations for continuing to hold out hope.